bpc 157 evidence human clinical trials review safety Here's a nice graphic on BPC-157 that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D If BPC-157 worked as well

Injectable BPC-157 delivers nearly 100% bioavailability while oral formulations likely deliver 1-10% or less

NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives immune evasion in urothelial carcinoma by elevating PD-L1 N-glycosylation

Long-term results depend on overall behavior change, not just injection use

Its unique profile (native gastric peptide, stable without carriers, effective at nanogram doses, modulating multiple interconnected neurotransmitter systems simultaneously, promoting actual neuronal repair rather than just symptomatic relief) distinguishes it from all existing psychiatric medications